A number of NZMCC projects are getting underway as the industry prepares for amendments to the Misuse of Drugs Act and the development of associated regulations.

NZMCC is working on a project to assess the clinical safety evidence for CBD products and another initiative focused on increasing prescriber and pharmacist training options.

We will be working with standards-setting bodies and regulators on a number of industry areas to establish robust standards for industry activities including:

  • testing of cannabinoids in plants and products;
  • cultivation and harvesting of cannabis for medicinal purposes;
  • extraction and processing methods;
  • labelling and advertising of medicinal cannabis products.

We are also discussing with Medical Cannabis Awareness New Zealand a set of proposed guidelines for colour-coding products sold in New Zealand based on their ratio of THC:CBD.